ARTELO BIOSCIENCES, INC. Additional Paid in Capital, Common Stock
ARTELO BIOSCIENCES, INC. (ARTL) had Additional Paid in Capital, Common Stock of $55.62 thousand as of 2017-02-28, per its 10-Q filed 2017-04-14.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2017-04-14
- 2017-02-28: Additional Paid in Capital, Common Stock $55.62K.
- 2016-11-30: Additional Paid in Capital, Common Stock $55.62K.
- 2016-08-31: Additional Paid in Capital, Common Stock $38.76K.
- 2016-05-31: Additional Paid in Capital, Common Stock $38.76K.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2017-02-28 | $55.62K 10-Q · filed 2017-04-14 |
| 2016-11-30 | $55.62K 10-Q · filed 2017-01-10 |
| 2016-08-31 | $38.76K 10-Q · filed 2017-04-14 |
| 2016-05-31 | $38.76K 10-Q · filed 2016-07-05 |
| 2016-02-29 | $38.76K 10-Q · filed 2016-04-01 |
| 2015-11-30 | $38.76K 10-Q · filed 2016-01-14 |
| 2015-08-31 | $38.76K 10-K · filed 2016-11-29 |
| 2015-05-31 | $31.65K 10-Q · filed 2015-07-15 |
| 2015-02-28 | $24.00K 10-Q · filed 2015-04-14 |
| 2014-08-31 | $24.00K 10-K · filed 2015-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |